Viewing Study NCT05940532


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-02-22 @ 4:13 AM
Study NCT ID: NCT05940532
Status: RECRUITING
Last Update Posted: 2023-07-11
First Post: 2023-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC
Sponsor: Hunan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module